Debt-to-equity of GeneDx Holdings Corp. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GeneDx Holdings Corp. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • GeneDx Holdings Corp. Debt-to-equity for the quarter ending 31 Dec 2025 was 70%, a 22% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GeneDx Holdings Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 70% -20% -22% 31 Dec 2025
Q3 2025 70% -23% -25% 30 Sep 2025
Q2 2025 77% -6.7% -8% 30 Jun 2025
Q1 2025 85% +11% +16% 31 Mar 2025
Q4 2024 89% +22% +32% 31 Dec 2024
Q3 2024 93% +23% +32% 30 Sep 2024
Q2 2024 83% +21% +33% 30 Jun 2024
Q1 2024 73% +16% +28% 31 Mar 2024
Q4 2023 68% +12% +22% 31 Dec 2023
Q3 2023 70% +22% +47% 30 Sep 2023
Q2 2023 63% +13% +27% 30 Jun 2023
Q1 2023 57% -123% -68% 31 Mar 2023
Q4 2022 56% +441% 31 Dec 2022
Q3 2022 48% +172% 30 Sep 2022
Q2 2022 49% +116% 30 Jun 2022
Q1 2022 180% 31 Mar 2022
Q4 2021 -386% 31 Dec 2021
Q3 2021 -124% 30 Sep 2021
Q2 2021 -66% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.